Security key
28658R106
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 55,706,408
- Total 13F value
- $100,272,719
- Share change
- -2,371,934
- SEC-reported price per share
- $1.80
- Number of holders
- 78
- Value change
- -$19,354,214
- Number of buys
- 44
- Number of sells
- 30
- Shares outstanding
- 57,061,882
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
78
Top holders
10
CLYM full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Climb Bio, Inc. SEC filings
Climb Bio, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 28658R106
Recent filing periods:
Ownership snapshot
Top reported holders of CLYM - Climb Bio, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Pontifax Management 4 G.P...
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
15/15
Latest evidence
30 Sep 2024
13D/G
13F
Lead comparable stake: 7.7%
13D/G row: Pontifax Management 4 G.P. (2015) Ltd.
Showing 1-6 of 15 holder rows.
Quick read
Pontifax Management 4 G.P. (2015) Ltd. leads the comparable SEC ownership view at 7.7%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Pontifax Management 4 G.P. (2015) Ltd.'s linked filing trail.
Comparable ownership
Top 5
Pontifax Management 4 G.P. (2015)...
7.7%
RA CAPITAL MANAGEMENT, L.P.
55%
Janus Henderson Group Ltd.
6.3%
Samsara BioCapital, LLC
4.6%
Boxer Capital, LLC
4.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Pontifax Management 4 G.P. (2015) Ltd. |
13D/G
Pontifax VI G.P. L.P.
|
7.7%
|
$12,911,822
5,206,380 shares
|
$0 | 27 Jun 2024 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
55%
|
$159,924,069
31,419,267 shares
|
— | 30 Sep 2024 |
| Janus Henderson Group Ltd. |
13F
Company
|
6.3%
|
$18,302,962
3,606,495 shares
|
— | 30 Sep 2024 |
| Samsara BioCapital, LLC |
13F
Company
|
4.6%
|
$13,280,390
2,609,114 shares
|
— | 30 Sep 2024 |
| Boxer Capital, LLC |
13F
Company
|
4.6%
|
$13,250,237
2,603,190 shares
|
— | 30 Sep 2024 |
| Deep Track Capital, LP |
13F
Company
|
3.8%
|
$11,040,938
2,169,143 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
78
Shares
55,706,408
Rows available
78
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q4 2025 Across Filers
Q4 2025 holders
64
Q4 2024 holders
78
Holder diff
14
| Investor | Q4 2025 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q4 2025 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend